Top Vaccines companies in Netherlands by EBITDA Margin
This ranking features the top 4 Vaccines companies in Netherlands ranked by EBITDA Margin, averaging a EBITDA Margin of -587.24%, for February 07, 2025.
Netherlands
Vaccines
EBITDA Margin
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
-15.68%
|
Dec. 31, 2023 | USD 662.53 | -0.67% |
|
Netherlands |
|
| 2 |
-350.44%
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
| 3 |
-597.09%
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
| 4 |
-1,385.76%
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
Frequently Asked Questions
-
Which Vaccines company in Netherlands has the highest EBITDA Margin ?
The Vaccines company in Netherlands with the highest EBITDA Margin is argenx SE (Brussels Stock Exchange: ARGX.BR) at -15.68%.
-
Which Vaccines company in Netherlands has the lowest EBITDA Margin ?
The Vaccines company in Netherlands with the lowest EBITDA Margin is NewAmsterdam Pharma Company N.V. (NasdaqGM: NAMS) at -1,385.76%.
-
What are the top 10 Vaccines companies in Netherlands by EBITDA Margin ?
The top 10 Vaccines companies in Netherlands by EBITDA Margin are argenx SE, Merus N.V., LAVA Therapeutics N.V. and NewAmsterdam Pharma Company N.V..
-
What are the bottom 10 Vaccines companies in Netherlands by EBITDA Margin ?
The bottom 10 Vaccines companies in Netherlands by EBITDA Margin are NewAmsterdam Pharma Company N.V., LAVA Therapeutics N.V., Merus N.V. and argenx SE.
